Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCoca-cola Euro. Regulatory News (CCEP)

Share Price Information for Coca-cola Euro. (CCEP)

Share Price is delayed by 15 minutes
Get Live Data
6,870.00    115.00 (1.70%)
Bid:
6,855.00
Ask:
6,860.00
Spread: 5.00 (0.073%)
Market Cap: £30.42b
CCEP Live PriceLast checked at - London Stock Exchange

Intraday Coca-cola Euro. Share Chart

Transactions in Own Shares

24 Jul 2025 07:00

RNS Number : 3249S
Coca-Cola Europacific Partners plc
24 July 2025
 

Coca-Cola Europacific Partners plc (the "Company")Transactions in Own Shares

 

The Company confirms that on 23 July 2025 it purchased a total of: (i) 35,513 ordinary shares of EUR 0.01 ("ordinary shares") on the US Trading Venues[1] and (ii) 15,520 ordinary shares on the London Trading Venues[2]; in both cases, from Goldman Sachs & Co. LLC, Goldman Sachs International or one of their affiliates, as detailed below.

The repurchased ordinary shares will be cancelled.

 

US Trading Venues

London Stock Exchange

CBOE Europe Limited

(CXE)

 

CBOE Europe Limited

(BXE)

Date of purchase

23 July 2025

23 July 2025

23 July 2025

23 July 2025

Aggregate number of ordinary shares purchased

35,513

9,854

1,654

4,012

Highest price paid (per ordinary share)

USD 100.2200

GBP 74.0000

GBP 73.8000

GBP 74.0000

Lowest price paid (per ordinary share)

USD 99.2200

GBP 73.2000

GBP 73.3000

GBP 73.2000

Volume weighted average price paid (per ordinary share)

USD 99.5743

GBP 73.5431

GBP 73.5366

GBP 73.4910

 

The purchases form part of the Company's share buyback programme announced on 14 February 2025 (the "Programme"). In connection with the Programme, the Company expects to repurchase up to EUR 1 billion of ordinary shares (in aggregate).

This announcement does not constitute, or form part of, an offer or solicitation of an offer for securities in any jurisdiction.

In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 as it applies in the UK (the Market Abuse Regulation), full details of the transactions, are set out in the Schedule to this announcement available through the link below:

http://www.rns-pdf.londonstockexchange.com/rns/3249S_1-2025-7-23.pdf 

 

CONTACTS

Company Secretariat

Clare Wardle

clare.wardle@ccep.com

Investor Relations

Sarah Willett

sarah.willett@ccep.com

Media Relations

Shanna Wendt

mediaenquiries@ccep.com

 

ABOUT CCEP

Coca-Cola Europacific Partners is one of the world's leading consumer goods companies. We make, move and sell some of the world's most loved brands - serving nearly 600 million consumers and helping over 4 million customers across 31 countries grow.

We combine the strength and scale of a large, multi-national business with an expert, local knowledge of the customers we serve and communities we support.

The Company is currently listed on Euronext Amsterdam, NASDAQ, London Stock Exchange and on the Spanish Stock Exchanges, and a constituent of both the NASDAQ 100 and FTSE 100 indices, trading under the symbol CCEP.

For more information about CCEP, please visit www.cocacolaep.com and follow CCEP on LinkedIn

 

 

 

 

 


[1] The "US Trading Venues" comprise Nasdaq and other applicable US trading venues.

[2] The "London Trading Venues" comprise the London Stock Exchange, CBOE Europe Limited (BXE) and CBOE Europe Limited (CXE). Goldman Sachs acquired CREST Depositary Interests on the London Trading Venues, which will be cancelled together with the underlying shares they represent.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSPKNBDDBKBKOB
Date   Source Headline
28th Mar 202510:45 amRNSCORRECTION: Transaction in Own Shares & Programme.
28th Mar 20257:00 amRNSTransactions in Own Shares and Programme Update
27th Mar 20257:00 amRNSTransaction in Own Shares
26th Mar 20257:00 amRNSTransaction in Own Shares
25th Mar 20257:00 amRNSTransaction in Own Shares
24th Mar 20257:00 amRNSTransaction in Own Shares
21st Mar 202511:15 amRNSAnnual Financial Report
21st Mar 20257:00 amRNSTransaction in Own Shares
20th Mar 20253:30 pmRNSDirector/PDMR Shareholding
20th Mar 20253:30 pmRNSDirector/PDMR Shareholding
20th Mar 20257:00 amRNSTransaction in Own Shares
19th Mar 20252:00 pmRNSDirector/PDMR Shareholding
19th Mar 20257:00 amRNSTransaction in Own Shares
18th Mar 20257:00 amRNSTransaction in Own Shares
17th Mar 20255:19 pmRNSBlock listing Interim Review
17th Mar 20257:00 amRNSTransaction in Own Shares
14th Mar 20257:00 amRNSTransaction in Own Shares
13th Mar 20257:01 amRNSTransaction in Own Shares
13th Mar 20257:00 amRNSRetirement of Director of CCEP
12th Mar 20255:00 pmRNSDirector/PDMR Shareholding
12th Mar 20257:00 amRNSTransaction in Own Shares
11th Mar 20257:00 amRNSTransaction in Own Shares
10th Mar 20257:00 amRNSTransaction in Own Shares
7th Mar 20257:00 amRNSTransaction in Own Shares
6th Mar 20253:00 pmRNSHolding(s) in Company
6th Mar 20257:00 amRNSTransaction in Own Shares
5th Mar 20256:00 pmRNSCCEP confirms admission to the FTSE 100 Index
5th Mar 20257:00 amRNSTransaction in Own Shares
4th Mar 20257:00 amRNSTransaction in Own Shares
3rd Mar 20251:30 pmRNSTotal Voting Rights
3rd Mar 20257:00 amRNSTransaction in Own Shares
28th Feb 20257:00 amRNSTransaction in Own Shares
27th Feb 20257:00 amRNSTransaction in Own Shares
26th Feb 20257:00 amRNSTransaction in Own Shares
25th Feb 20257:00 amRNSTransaction in Own Shares
24th Feb 20257:00 amRNSTransaction in Own Shares
21st Feb 20257:00 amRNSTransaction in Own Shares
20th Feb 20253:30 pmRNSDirector/PDMR Shareholding
20th Feb 20257:00 amRNSTransaction in Own Shares
19th Feb 20257:00 amRNSTransaction in Own Shares
14th Feb 20257:02 amRNSCommittee Composition
14th Feb 20257:02 amRNSDirectorate Change
14th Feb 20257:01 amRNSCCEP announces share buyback Programme
14th Feb 20257:00 amRNSPreliminary Unaudited Results Q4 & FY 2024
3rd Feb 20252:30 pmRNSTotal Voting Rights
27th Jan 20253:30 pmRNSDirector/PDMR Shareholding
22nd Jan 20253:30 pmRNSDirector/PDMR Shareholding
14th Jan 20254:30 pmRNSDirector/PDMR Shareholding
20th Dec 202411:00 amRNSDirector/PDMR Shareholding
16th Dec 20242:00 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.